Pilot and Feasibility Studies

Scope & Guideline

Advancing healthcare through innovative pilot research.

Introduction

Delve into the academic richness of Pilot and Feasibility Studies with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationPILOT FEASIBILITY ST / Pilot Feasibility Stud.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Pilot and Feasibility Studies' is dedicated to the dissemination of research that focuses on the initial stages of health interventions, particularly those that assess feasibility, acceptability, and preliminary efficacy. It serves as a platform for studies that aim to bridge the gap between theoretical research and practical application in healthcare settings. The journal emphasizes the importance of pilot studies in informing the design and implementation of larger-scale trials and encourages innovative methodologies to address real-world health challenges.
  1. Feasibility and Acceptability Studies:
    The journal prioritizes studies that explore the feasibility and acceptability of health interventions across various populations and settings. These studies provide critical insights into whether proposed interventions can be realistically implemented and received positively by the target audience.
  2. Intervention Development and Testing:
    Research focused on the development and early testing of innovative health interventions is a core area. This includes studies that test new approaches to treatment, prevention, or health promotion before larger trials are conducted.
  3. Methodological Innovations:
    The journal encourages submissions that introduce or evaluate new methodologies for conducting pilot and feasibility studies, including mixed-methods approaches, adaptive designs, and novel data collection techniques.
  4. Health Outcomes and Impact Assessment:
    Research that assesses the potential health outcomes and impact of interventions, even at the pilot stage, is emphasized. This includes studies that gather preliminary data on effectiveness and inform future research directions.
  5. Patient and Public Involvement:
    The journal values research that incorporates patient and public involvement in the design and implementation of studies, ensuring that the perspectives and needs of stakeholders are considered.
The journal 'Pilot and Feasibility Studies' has witnessed significant trends and emerging themes in research, reflecting the changing landscape of health intervention studies. This section highlights the key areas gaining traction among recent publications.
  1. Digital Health Interventions:
    There is a notable increase in studies exploring digital health interventions, including mobile applications and telehealth solutions, particularly in response to the COVID-19 pandemic. These studies focus on leveraging technology to enhance patient engagement and access to care.
  2. Multimodal Interventions:
    Research focusing on multimodal interventions that combine physical, psychological, and social components is on the rise. This reflects a broader understanding of health as a multifaceted issue that requires comprehensive solutions.
  3. Community-Based Interventions:
    Emerging themes highlight the importance of community-based interventions designed to address local health needs. These studies often involve collaboration with community stakeholders to ensure that interventions are culturally appropriate and effective.
  4. Mental Health and Well-being:
    There is an increasing emphasis on pilot studies addressing mental health and well-being, particularly interventions targeting anxiety, depression, and stress management. This trend underscores the growing recognition of mental health as a critical component of overall health.
  5. Health Equity and Inclusion:
    Research that examines health equity and the inclusion of marginalized populations in health studies is gaining prominence. This reflects a commitment to understanding and addressing disparities in health outcomes and access to care.

Declining or Waning

While 'Pilot and Feasibility Studies' continues to thrive in various areas of health research, certain themes appear to be declining in prominence based on recent publications. This section outlines those areas that are gradually being phased out or are receiving less attention.
  1. Traditional Clinical Trials:
    There seems to be a waning interest in conventional clinical trial designs without innovative adaptations. The focus is increasingly shifting towards more flexible and adaptive methodologies that better accommodate real-world applications.
  2. Single-Dimensional Interventions:
    Studies that explore single-dimensional interventions without considering multifaceted approaches to health care are less frequently published. There is a growing recognition of the complexity of health issues which necessitates integrated intervention strategies.
  3. Generic Health Promotion:
    Research that focuses on generic health promotion strategies, rather than tailored or context-specific interventions, appears to be declining. The emphasis is now on personalized and culturally sensitive approaches that resonate with specific populations.
  4. Exploratory Pilot Studies Without Clear Outcomes:
    There is a decrease in the publication of exploratory studies that do not articulate clear outcomes or objectives. The journal emphasizes the need for pilot studies to have defined goals that contribute to the field of health interventions.

Similar Journals

Contemporary Clinical Trials

Elevating Standards in Clinical Trial Design
Publisher: ELSEVIER SCIENCE INCISSN: 1551-7144Frequency: 6 issues/year

Contemporary Clinical Trials, published by Elsevier Science Inc, stands at the forefront of clinical research, providing a dedicated platform for the dissemination of innovative studies and methodologies in medicine and pharmacology. With an impressive impact factor reflecting its consistent contributions to the field, this journal is categorized in the Q1 quartile for both Medicine (miscellaneous) and Pharmacology (medical) as of 2023. The journal's scope encompasses a broad range of topics pertinent to clinical trial design, execution, and analysis, aiming to enhance the effectiveness and safety of therapeutic interventions. Operating under an Open Access model, it ensures that the latest research is accessible to a global audience, fostering collaboration and discussion among researchers, professionals, and students alike. In publishing high-quality articles since its inception in 2005, Contemporary Clinical Trials continues to shape the future of clinical research with its commitment to excellence and innovation.

International Health

Championing Global Health Equity and Innovation
Publisher: OXFORD UNIV PRESSISSN: 1876-3413Frequency: 6 issues/year

International Health, published by Oxford University Press, is a leading peer-reviewed journal dedicated to the exploration and advancement of health and healthcare practices across the globe. With its ISSN 1876-3413 and E-ISSN 1876-3405, the journal focuses on a wide variety of topics within the realm of international health, catering to a diverse audience of researchers, professionals, and students. It currently holds a prestigious position in the 2023 quartile rankings, being categorized as Q1 in Health (Social Science) and Q2 in both Medicine (Miscellaneous) and Public Health, Environmental and Occupational Health, reflecting its significant impact within these fields. Although the journal is not open access, it remains a valuable resource, providing crucial insights and fostering discussion around health systems, public policy, and global health challenges from 2009 to 2024. With a strong emphasis on empirical research and innovative practices, International Health serves as a vital platform for knowledge dissemination and scholarly discourse, making substantial contributions to the field of public health worldwide.

SEXUALLY TRANSMITTED DISEASES

Advancing knowledge in the fight against STDs.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0148-5717Frequency: 12 issues/year

SEXUALLY TRANSMITTED DISEASES is a premier academic journal published by Lippincott Williams & Wilkins, dedicated to the investigation and dissemination of research on sexually transmitted infections and related public health issues. This journal, with the ISSN 0148-5717 and E-ISSN 1537-4521, has been a cornerstone of the field since its inception in 1977, with coverage extended to 2024. A testament to its scholarly impact, it holds prestigious rankings in the top quartiles across various categories including Q1 in Dermatology and Q1 in Public Health, Environmental and Occupational Health, underscoring its importance in driving forward critical discussions and advancements in these vital areas of health. With an emphasis on rigorous research and the latest scientific findings, the journal not only serves researchers and professionals but also informs clinical practices, shaping public health policies. While it is not an Open Access journal, it offers a wealth of subscription-based resources highly regarded for their quality and relevance within the medical community.

HEALTH TECHNOLOGY ASSESSMENT

Illuminating the path to effective health technology solutions.
Publisher: NIHR JOURNALS LIBRARYISSN: 1366-5278Frequency:

HEALTH TECHNOLOGY ASSESSMENT is a prestigious open-access journal published by the NIHR Journals Library, focusing on advancing the science of health technology assessment through robust research and critical analysis in the fields of Health Policy and Medicine. Since its inception in 2001, this journal has fostered a multidisciplinary approach to evaluating health technologies, offering invaluable insights to researchers, healthcare professionals, and policymakers. With an impressive Q1 ranking in both Health Policy and Medicine (miscellaneous) for 2023, it stands at the forefront of academic discourse, reflecting a high-impact factor and an esteemed reputation within its respective categories. The journal not only publishes original research articles, but also reviews and case studies that illuminate the complexities of health technology in real-world applications. Established and based in the United Kingdom, HEALTH TECHNOLOGY ASSESSMENT strives to encourage evidence-based decision-making, making it an essential resource for anyone committed to enhancing healthcare outcomes through innovative technology assessments.

Istanbul Medical Journal

Fostering collaboration in the heart of medicine.
Publisher: GALENOS PUBL HOUSEISSN: 2619-9793Frequency: 4 issues/year

Istanbul Medical Journal is a prominent open-access journal published by GALENOS PUBL HOUSE, dedicated to disseminating high-quality research in the field of medicine since its inception in 1994. The journal, identifiable by its ISSN 2619-9793 and E-ISSN 2148-094X, serves as a critical platform for healthcare professionals, researchers, and students who aim to share innovative studies and advancements within diverse medical domains. Its commitment to open access ensures that crucial findings and discussions are readily available to a global audience, fostering collaboration and knowledge exchange among the scientific community. Located in Istanbul, Türkiye, the journal not only contributes to the medical literature landscape but also emphasizes the importance of accessibility in research, aligning with current academic trends that prioritize the transmission of knowledge across barriers. As a resource for those involved in healthcare and medical research, the Istanbul Medical Journal plays a vital role in shaping future developments in medicine.

Pragmatic and Observational Research

Bridging the Gap Between Research and Practice
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-7266Frequency: 1 issue/year

Pragmatic and Observational Research, published by DOVE MEDICAL PRESS LTD, is a distinguished open-access journal that has been advancing knowledge in the fields of clinical practices and epidemiological studies since its inception in 2010. With an ISSN of 1179-7266, this journal serves as a vital platform for researchers, healthcare professionals, and students to disseminate and access high-quality research that influences real-world health outcomes. Although the journal does not currently have an HIndex or Scopus ranking, its commitment to open access ensures that all articles are readily available to a global audience, facilitating broad engagement and collaboration. The journal focuses on pragmatic and observational methodologies, emphasizing studies that inform evidence-based practices in health care, thereby playing a crucial role in aligning research with practical health challenges. By contributing to the understanding of health interventions and observational data, Pragmatic and Observational Research continues to uphold its mission of improving health care through rigorous research.

Reviews on Recent Clinical Trials

Advancing the Frontiers of Clinical Research.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1574-8871Frequency: 4 issues/year

Reviews on Recent Clinical Trials, published by Bentham Science Publishers Ltd, is a distinguished journal in the medical and pharmacological fields, assessing the latest advancements in clinical research since its inception in 2006. With a focus on integrating multidisciplinary approaches to evaluating clinical trial methodologies, the journal caters to a diverse audience of researchers, professionals, and students keen on enhancing their knowledge and understanding of innovative therapeutic strategies and drug developments. Notably positioned in the Q3 quartile as ranked by Scopus for both 'Medicine (miscellaneous)' and 'Pharmacology', the journal illustrates a growing academic influence, evidenced by its Scopus rankings—holding a commendable 72nd percentile in general medicine and a 33rd percentile in pharmacology. While the journal is not open access, it remains committed to disseminating high-quality, peer-reviewed content that drives forward the conversation in clinical research. For those interested in staying abreast of novel findings and comprehensive reviews within the clinical trial landscape, Reviews on Recent Clinical Trials stands out as an essential resource.

Journal of Patient-Centered Research and Reviews

Unlocking the potential of patient-centered methodologies.
Publisher: AURORA HEALTH CARE, INCISSN: 2330-068XFrequency: 4 issues/year

The Journal of Patient-Centered Research and Reviews, with its ISSN 2330-068X and E-ISSN 2330-0698, is a prominent publication dedicated to advancing the field of patient-centered healthcare. Published by AURORA HEALTH CARE, INC, this open access journal has been providing vital insights into patient care methodologies since 2014, ensuring that research is accessible to practitioners, researchers, and students worldwide. The journal covers a spectrum of topics within healthcare research, focusing on optimizing patient outcomes through innovative practices and evidence-based strategies. By fostering dialogue between healthcare providers and patients, the journal aims to enhance understanding and implementation of patient-centered approaches in clinical settings. With a commitment to enriching the healthcare landscape, the Journal of Patient-Centered Research and Reviews stands as a crucial resource for those dedicated to improving patient experiences and outcomes.

BMJ Innovations

Pioneering advancements in medical technology and methodologies.
Publisher: BMJ PUBLISHING GROUPISSN: 2055-8074Frequency: 4 issues/year

BMJ Innovations, published by the esteemed BMJ Publishing Group, serves as a vital platform for advancing the field of medical innovation. Established in 2015, this peer-reviewed journal has quickly gained recognition, currently holding a Q3 ranking in the miscellaneous Medicine category with a notable Scopus rank of #123 out of 636, placing it in the top 20% of its field. With a focus on disseminating groundbreaking research, clinical practices, and case studies that drive innovation in healthcare, BMJ Innovations aims to bridge the gap between theory and practical application, appealing to researchers, healthcare professionals, and students. The journal not only provides significant insights into emerging medical technologies and methodologies but also engages with the ongoing discourse in medicine, shaping the future of patient care. Although it does not follow an Open Access model, access options are available to ensure wide dissemination of its impactful content. The journal's commitment to excellence and contribution to the evolving medical landscape underscores its importance as a hub for innovative thinking in the UK and beyond.

PANMINERVA MEDICA

Advancing medical knowledge since 1959.
Publisher: EDIZIONI MINERVA MEDICAISSN: 0031-0808Frequency: 4 issues/year

PANMINERVA MEDICA is a distinguished journal published by EDIZIONI MINERVA MEDICA, focusing on the multifaceted field of medicine since its inception in 1959. With an ISSN of 0031-0808 and an E-ISSN of 1827-1898, this journal is esteemed for its rigorous peer-review process and its contribution to clinical and experimental research across various domains of medicine. Based in Italy, it holds a commendable position in the 2023 Scopus rankings, where it is placed in the 84th percentile among general medicine journals, highlighting its relevance and scholarly impact. As a Q3 category journal in the medicine (miscellaneous) quartiles, PANMINERVA MEDICA is committed to disseminating high-quality research, fostering scientific dialogue, and advancing medical knowledge globally. While currently not offering open access, it serves as a vital resource for researchers, practitioners, and students seeking to stay at the forefront of medical advancements. The journal is poised to continue its tradition of excellence as it converges into 2024, ensuring robust discourse in healthcare and clinical practices.